PATENT CLAIM ANALYSIS

Application Number: 15866780
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "005000"]

Abstract:
Methods, devices and systems for capturing biomarkers are provided. In particular, methods, compositions, and systems that utilize affinity capture devices comprising a processing chamber, affinity capture agent and porous membrane are provided.

Claim (Index 3):
The method of  claim 2 , wherein said cancer biomarker is selected from the group consisting of prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), early prostate cancer antigen-1 (EPCA-1), early prostate cancer antigen-2 (EPCA-2), CA-125, B-HGG, CA-19-9, carcioembryonic antigen (CEA), EGFR, KIT, ERB2, Cathepsin D, human kallikrein 2 (hK2), alpha-methylacyl coenzyme A racemase (AMACR), galectin-3, hepsin, macrophage inhibitory cytokine (MIC-1), insulin-like growth factor binding protein 3 (IGFBP3), sFRP1, 14-3-3 zeta, 14-3-3 delta, Sparc 1, PLAP, metalloproteinase-2 (MMP-2), metalloproteinase-9 (MMP-9), MHC-I, and FasL.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13009285', '13009393', '12591226', '15801269', '13639756']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7075282059423247
- 35 USC 102 Novelty (BERT): 0.5223524998216497
- Combined Prediction Score: 0.6890106353302572
- Mean Citation Score: 306.071034
- Max Citation Score: 351.34927000000016
- Similarity Product: 233.5717760045457

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test